KALA BIO, Inc.
KALA
$5.10
$0.050.99%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 24.22% | 5.24% | -2.83% | 8.01% | 18.32% |
| Total Depreciation and Amortization | 3.03% | -1.43% | -20.25% | -20.78% | -14.29% |
| Total Amortization of Deferred Charges | -40.38% | -4.17% | 4.21% | 3.96% | -5.17% |
| Total Other Non-Cash Items | -7.98% | -20.05% | 172.16% | 21.19% | -10.84% |
| Change in Net Operating Assets | -24.73% | 147.18% | -85.54% | -370.18% | -244.70% |
| Cash from Operations | 18.63% | 40.25% | -60.06% | -21.33% | -11.98% |
| Capital Expenditure | -- | -885.71% | 67.97% | 83.18% | 87.96% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -885.71% | -100.93% | 99.64% | 87.96% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -38.10% | 1,947.89% | -- | 387.15% | -99.86% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -100.00% | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -0.84% | -- | -- | -- | 94.17% |
| Cash from Financing | -101.60% | 162.17% | -550.00% | 387.15% | 195.31% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -270.67% | 138.29% | -173.38% | 139.29% | 65.14% |